共 207 条
[1]
Schett G(2005)Mechanisms of disease: the link between RANKL and arthritic bone disease Nat Clin Pract Rheumatol 1 47-54
[2]
Hayer S(2010)Rheumatoid arthritis Lancet 376 1094-108
[3]
Zwerina J(2000)The links between joint damage and disability in rheumatoid arthritis Rheumatology (Oxford) 39 122-32
[4]
Redlich K(2010)The role of interleukin 6 in the pathophysiology of rheumatoid arthritis Ther Adv Musculoskelet Dis 2 247-56
[5]
Smolen JS(1988)Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides Arthritis Rheum 31 784-8
[6]
Scott DL(1990)IL-6 is produced by osteoblasts and induces bone resorption J Immunol 145 3297-303
[7]
Wolfe F(1996)Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation J Bone Miner Res 11 88-95
[8]
Huizinga TW(1999)Uncoupling of bone metabolism in rheumatoid arthritis patients with or without joint destruction: assessment with serum type I collagen breakdown products Bone 24 381-5
[9]
Scott DL(2008)IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-α and IL-17 Rheumatology (Oxford) 47 1635-40
[10]
Pugner K(1993)Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6 Proc Natl Acad Sci U S A 90 11924-8